Fadraciclib, CAS [[1070790-89-4]]

Produktübersicht

• Artikelname: Fadraciclib, CAS [[1070790-89-4]]
• Artikelnummer: BYT-ORB1296241
• Hersteller Artikelnummer: orb1296241
• Alternativnummer: BYT-ORB1296241-1, BYT-ORB1296241-1, BYT-ORB1296241-10, BYT-ORB1296241-100, BYT-ORB1296241-2, BYT-ORB1296241-25, BYT-ORB1296241-5, BYT-ORB1296241-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: CDK9, CDK, CDK2, Cyclin dependent kinase, CYC 065, CYC065, CYC-065, inhibit, Fadraciclib, Inhibitor

Produktbeschreibung

Fadraciclib (CYC065) is a potent, orally bioavailable inhibitor targeting CDK2 and CDK9 kinases with IC50 values of 5 nM and 26 nM, respectively. It is used in cancer research to study transcriptional regulation and apoptosis, demonstrating activity in both in vitro cell-based assays and in vivo tumor models.

Produkteigenschaften

• Molekulargewicht: 397.52
• Reinheit: 99.75% (May vary between batches)
• CAS Nummer: [1070790-89-4]
• Formel: C21H31N7O
• Target-Kategorie: CDK

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: DMSO:100 mg/mL (251.56 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (10.06 mM)